go-v.orgdoi

Gut Microbiota Modulation: A New Frontier in the Management of Gastrointestinal and Metabolic Diseases

Ricardo Xavier Cárdenas Zambrano, Erick Adolfo Meza Soto, José Enrique González Araujo, Daniel Armando Walteros Acero, Erwin Giovanny Mercado Estrada, Saúl Cruz Ramírez, Pedro Xavier Faggioni Paladines, Yahir Oliver Balderas · IECCMEXICO · 2025

  • DOI 10.64784/013
  • Publisher OpenAlex
  • Type article
  • Issued 2025

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

IECCMEXICO · OpenAlex · article · 2025

Abstract

The gut microbiota plays a critical role in metabolic, immune, and gastrointestinal homeostasis. Dysbiosis—characterized by reduced microbial diversity, loss of Bifidobacterium and Akkermansia muciniphila, and an increased Firmicutes/Bacteroidetes ratio—has been consistently linked to insulin resistance, chronic inflammation, and metabolic syndrome. This review analyzes multidisciplinary evidence on microbiota modulation through dietary, probiotic, postbiotic, and transplantation-based interventions, integrating findings from global research and contextualizing them within the health frameworks of Mexico, Colombia, and Ecuador.

The results highlight that short-chain fatty acids (SCFAs), primarily butyrate and propionate, mediate the beneficial effects of microbial metabolism by enhancing epithelial barrier integrity, regulating appetite hormones, and reducing systemic inflammation through GPR41, GPR43, and GPR109A signaling. Clinical data demonstrate that lean-donor fecal microbiota transplantation and Akkermansia muciniphila supplementation improve insulin sensitivity and lipid metabolism, while postbiotics offer standardized, colonization-independent bioactivity.

Regionally, implementation strategies should follow a tiered model: fiber-centered personalized nutrition, ISAPP-aligned microbial formulations, and ecological reset through standardized consortia or fecal microbiota transplantation in severe dysbiosis. These interventions align with the United Nations Sustainable Development Goals (SDG 3, 9, and 12) by promoting sustainable, equitable, and evidence-based healthcare. Overall, microbiota modulation represents a mechanistically grounded and culturally adaptable tool for the prevention and treatment of chronic diseases, bridging global precision medicine with local dietary and ecological realities.

Open the resolved locator · 10.64784/013

Metadata licence: OpenAlex metadata (CC0)